高级检索
当前位置: 首页 > 详情页

MiR-9-5p promotes M1 cell polarization in osteoarthritis progression by regulating NF-κB and AMPK signaling pathways by targeting SIRT1.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Rheumatology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan Province, China [2]The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan Province, China
出处:
ISSN:

摘要:
To investigate the roles and regulatory mechanisms of miR-9-5p in the development of osteoarthritis (OA).Synovial tissues from mouse OA model and control groups were collected and miR-9-5p expression levels and macrophage markers were measured with qPCR. The function of miR-9-5p in macrophage polarization was analyzed by flow cytometry and qPCR. Various databases were employed to screen the target genes one of which was validated with dual-luciferase analysis. Following the validation, rescue research was applied, and the signaling pathways were analyzed with Western blotting. Finally, the role of miR-9-5p in the progression of OA was validated in the mouse model.MiR-9-5p was highly expressed in the synovial tissues of the OA model and was positively associated with M1 markers. Function analysis demonstrated that miR-9-5p could promote the progression of OA by promoting M1 polarization and inhibiting M2 polarization in vivo and in vitro. The mechanism analysis demonstrated that miR-9-5p could regulate macrophage polarization via NF-κB and AMPK signaling pathways by inhibiting SIRT1 expression.MiR-9-5p could promote M1 polarization and OA progression by regulating NF-κB and AMPK signaling pathways by inhibiting SIRT1 expression.Copyright © 2021 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 免疫学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 免疫学 2 区 药学
JCR分区:
出版当年[2020]版:
Q2 IMMUNOLOGY Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Rheumatology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan Province, China [2]The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan Province, China
通讯作者:
通讯机构: [1]Department of Rheumatology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan Province, China [2]The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan Province, China [*1]Department of Rheumatology, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, No. 157 Jinbi Road, Kunming 650032, Yunnan, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:86913 今日访问量:0 总访问量:707 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号